ICUI 71.16 Icu Medical $ICUI Hit a 52 week high of 72.30

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ICUI 71.16 Icu Medical $ICUI Hit a 52 week high of 72.30 Closing the day 11/07/14 at 71.16 -0.89 -1.24% With a day low of 70.55 and a total volume of 110,435.

ICUI Recent Posts: http://investorshangout.com/ICU-Medical-Inc-ICUI-54414/

ICUI Icu Medical Recent Headline News

BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), BIOS: 5.69 (+0.17)

Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), OMCL: 31.89 (-0.28)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), GWPH: 73.97 (-0.41), HSP: 56.32 (-0.32)

Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), GWPH: 73.97 (-0.41), SPHS: 2.82 (-0.19)

Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), GWPH: 73.97 (-0.41), RMTI: 10.55 (+1.22)

CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), CVS: 88.38 (-0.05)

Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), HAE: 36.82 (-0.27)

14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 71.16 (-0.89)

Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.16 (-0.89), CSII: 29.36 (-0.51), ABAX: 51.63 (-2.21), GWPH: 73.97 (-0.41)

Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), GWPH: 73.97 (-0.41), ATRC: 16.86 (+0.01)

Merge Healthcare Q3 Revenues Top Estimates, Earnings Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:10PM CDT
Merge Healthcare Incorporated (MRGE) reported third-quarter 2014 adjusted net income per share of 4 cents.
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), MRGE: 3.06 (+0.03)

Walgreens Banks on Alliance Boots Deal, Headwinds Persist - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:35PM CDT
On Oct 27, we issued an updated research report on Walgreen Co. (WAG).
ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), ALR: 39.37 (-0.70), WAG: 66.92 (+0.27)

ICU Medical Has Returned 13.3% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Tue Oct 28, 9:59AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 13.26% as of today's recent price of $70.45.
ICUI: 71.16 (-0.89)

ICU Medical, Inc. Announces Time of Third Quarter 2014 Earnings Call
GlobeNewswire - Mon Oct 27, 3:10PM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its third quarter 2014 earnings release conference call.
ICUI: 71.16 (-0.89)

Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)

Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), CRDC: 0.96 (+0.01)

Zimmer Beats on Earnings and Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:03PM CDT
Zimmer Holdings (ZMH) reported third-quarter 2014 adjusted earnings per share of $1.35.
ZMH: 108.19 (-2.00), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), ALR: 39.37 (-0.70)

Boston Scientific Earnings, Revenues in Line; View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 1:50PM CDT
Boston Scientific (BSX) reported adjusted EPS of 20 cents in the third quarter of 2014, 17.6% ahead of the year-ago adjusted number.
BSX: 13.24 (-0.12), ICUI: 71.16 (-0.89), ABAX: 51.63 (-2.21), ALR: 39.37 (-0.70)

Strength Seen in Cerus (CERS): Stock Gains 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 8:46AM CDT
Cerus (CERS) was a big mover last session, with shares rising over 6% on the day.
CERS: 4.01 (+0.03), ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21)

ICU Medical Inc. (ICUI) Stock Research Links

ICUI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading